- Conditions
- Intraoperative Bleeding, Liver Diseases, Gallbladder Diseases, Hemorrhage, Surgical
- Interventions
- GATT-Patch, SURGICEL® Original
- Device
- Lead sponsor
- GATT Technologies BV
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 53 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 6
- States / cities
- Los Angeles, California • St Louis, Missouri • Pennington, New Jersey + 3 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–10
of 10
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Hemostasis, Hemostatic Techniques
- Interventions
- ETHIZIA, SURGICEL Original
- Device
- Lead sponsor
- Ethicon, Inc.
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 108 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 6
- States / cities
- Los Angeles, California • St Louis, Missouri • Pennington, New Jersey + 3 more
- Conditions
- Hemorrhage
- Interventions
- EVARREST® Fibrin Sealant Patch, Standard of Care (SoC)
- Biological · Other
- Lead sponsor
- Ethicon, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 102 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 10
- States / cities
- Birmingham, Alabama • Augusta, Georgia • Chicago, Illinois + 5 more
- Conditions
- Soft Tissue Surgical Bleeding
- Interventions
- Fibrin Sealant (FS) Grifols, Surgicel®
- Biological · Device
- Lead sponsor
- Grifols Biologicals, LLC
- Industry
- Eligibility
- Not listed
- Enrollment
- 327 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 17
- States / cities
- Florence, Alabama • Pasadena, California • Bridgeport, Connecticut + 13 more
- Conditions
- Hemorrhage
- Interventions
- TachoSil®, Surgicel® Original
- Biological · Device
- Lead sponsor
- Takeda
- Industry
- Eligibility
- Not listed
- Enrollment
- 253 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 17
- States / cities
- Los Angeles, California • Washington D.C., District of Columbia • Chicago, Illinois + 14 more
- Conditions
- Bleeding
- Interventions
- TachoSil®, Surgicel® Original
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 37
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Long Beach, California + 25 more
- Conditions
- Hemorrhage
- Interventions
- TachoSil, Surgicel Original
- Biological
- Lead sponsor
- Corza Medical GmbH
- Industry
- Eligibility
- 1 Month and older
- Enrollment
- 116 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 9
- States / cities
- Torrance, California • Lakewood, Colorado • Washington D.C., District of Columbia + 6 more
- Conditions
- Pudendal Nerve
- Interventions
- Robotic Assisted Laparoscopic Prostatectomy, Application of Absorbable Hemostat, Application of dehydrated human amniotic membrane
- Procedure · Other
- Lead sponsor
- MiMedx Group, Inc.
- Industry
- Eligibility
- 45 Years to 70 Years · Male only
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Parenchymous Tissue Surgical Bleeding
- Interventions
- Fibrin Sealant Grifols, Surgicel®
- Biological · Device
- Lead sponsor
- Instituto Grifols, S.A.
- Industry
- Eligibility
- Not listed
- Enrollment
- 325 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 26
- States / cities
- Loma Linda, California • Los Angeles, California • New Haven, Connecticut + 21 more
- Conditions
- Nephrolithiasis
- Interventions
- Floseal, Surgicel, Surgiflo, Balloon Tamponade
- Device · Procedure
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 92 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- New York, New York